We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+4.24%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$4.31B
AUM Growth
+$60.9M
Cap. Flow
-$73.3M
Cap. Flow %
-1.7%
Top 10 Hldgs %
16.36%
Holding
590
New
34
Increased
175
Reduced
265
Closed
22

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$26.3M
2
OKE icon
Oneok
OKE
+$18.5M
3
BAX icon
Baxter International
BAX
+$17.2M
4
AVY icon
Avery Dennison
AVY
+$12.8M
5
ICUI icon
ICU Medical
ICUI
+$11.8M

Top Sells

Rank Stock Value
1
AYI icon
Acuity Brands
AYI
+$23.3M
2
PPG icon
PPG Industries
PPG
+$22.4M
3
EFX icon
Equifax
EFX
+$19M
4
OKS
Oneok Partners LP
OKS
+$17.7M
5
MDT icon
Medtronic
MDT
+$17.5M

Sector Composition

Rank Sector Weight
1 Healthcare 17.99%
2 Industrials 16.07%
3 Financials 14.59%
4 Technology 13.97%
5 Consumer Discretionary 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADI icon
276
Analog Devices
ADI
$181B
$2.68M 0.06%
31,124
-800
-3% -$64.5K
ECON icon
277
Columbia Emerging Markets Consumer ETF
ECON
$327M
$2.63M 0.06%
95,600
QCOM icon
278
Qualcomm
QCOM
$176B
$2.6M 0.06%
50,219
-7,902
-14% -$418K
JCI icon
279
Johnson Controls International
JCI
$87.5B
$2.53M 0.06%
62,904
-931
-1% -$37.7K
VWO icon
280
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$2.53M 0.06%
58,160
+3,626
+7% +$157K
BCR
281
DELISTED
CR Bard Inc.
BCR
$2.47M 0.06%
7,715
-100
-1% -$32K
ANGI icon
282
Angi Inc
ANGI
$224M
$2.46M 0.06%
19,732
-21,653
-52% -$2.65M
IDXX icon
283
Idexx Laboratories
IDXX
$42.9B
$2.46M 0.06%
15,797
+238
+2% +$37.6K
IWB icon
284
iShares Russell 1000 ETF
IWB
$47.7B
$2.45M 0.06%
17,540
+210
+1% +$28.8K
VXF icon
285
Vanguard Extended Market ETF
VXF
$30.3B
$2.44M 0.06%
22,792
+254
+1% +$26.2K
IAU icon
286
iShares Gold Trust
IAU
$63B
$2.44M 0.06%
98,888
+1,163
+1% +$28.6K
APA icon
287
APA Corp
APA
$12.8B
$2.37M 0.06%
51,772
+150
+0.3% +$6.61K
MPLX icon
288
MPLX
MPLX
$59.5B
$2.36M 0.05%
67,333
+20,469
+44% +$707K
OCLR
289
DELISTED
Oclaro Inc.
OCLR
$2.33M 0.05%
+270,265
New +$2.43M
VTI icon
290
Vanguard Total Stock Market ETF
VTI
$654B
$2.3M 0.05%
17,744
+213
+1% +$27K
SRI icon
291
Stoneridge
SRI
$209M
$2.29M 0.05%
115,773
+6,237
+6% +$103K
APD icon
292
Air Products & Chemicals
APD
$66.3B
$2.25M 0.05%
14,888
MCHX icon
293
Marchex
MCHX
$79.7M
$2.25M 0.05%
728,640
-15,640
-2% -$46.6K
TXN icon
294
Texas Instruments
TXN
$255B
$2.24M 0.05%
24,999
+3,260
+15% +$268K
MMP
295
DELISTED
Magellan Midstream Partners, L.P.
MMP
$2.23M 0.05%
31,331
EXPR
296
DELISTED
Express, Inc.
EXPR
$2.22M 0.05%
16,401
+3,005
+22% +$379K
DVA icon
297
DaVita
DVA
$15.1B
$2.21M 0.05%
37,155
-21,848
-37% -$1.32M
DELL icon
298
Dell
DELL
$283B
$2.16M 0.05%
99,778
INFO
299
DELISTED
IHS Markit Ltd. Common Shares
INFO
$2.09M 0.05%
47,465
+973
+2% +$44.8K
GIL icon
300
Gildan
GIL
$9.25B
$2.08M 0.05%
66,410
-27,055
-29% -$828K

Similar funds

Segall Bryant & Hamill's Q3 2017 Portfolio in Review

As of Q3 2017, Segall Bryant & Hamill held 590 positions worth $4.31B, up 1.4% from $4.24B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Segall Bryant & Hamill's Q3 2017 filing shows 34 new, 175 increased, 265 reduced and 22 closed positions. Its largest new stake was ICU Medical: 67,735 shares worth $12.6M. The largest sale was Acuity Brands, an estimated $23.3M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

  • Segall Bryant & Hamill's largest Q3 2017 buy was ICU Medical: 67,735 shares worth $12.6M.
  • Segall Bryant & Hamill added most to Thermo Fisher Scientific in Q3 2017, an estimated $26.3M increase.
  • Segall Bryant & Hamill's biggest Q3 2017 reduction was Acuity Brands, cutting an estimated $23.3M.
  • Segall Bryant & Hamill fully exited Oneok Partners LP in Q3 2017, selling an estimated $17.7M.
  • Segall Bryant & Hamill's ten largest holdings make up 16% of its $4.31B portfolio in Q3 2017.
  • Segall Bryant & Hamill opened 34 new positions and closed 22 in Q3 2017.
  • Segall Bryant & Hamill's portfolio value rose 1.4% quarter-over-quarter to $4.31B.

Based on Segall Bryant & Hamill's 13F filing for Q3 2017, filed 14 Nov 2017.